Lawmakers debate safety of importing drugs
March 12th, 2009 by Jennifer Walker-Journey
Congress continues to debate the notion of allowing people to buy inexpensive drug from other countries, as the Obama administration is encouraging, but the stickler seems to be ensuring the safety of those imported drugs, according to Portfolio.
Even on the campaign trail, Obama’s camp said it would support the plan but that there would have to be measures in place to ensure the FDA was properly inspecting the plants where drugs are being manufactured.
After all, it was just one year ago that hundreds of people became ill and more than 80 died after receiving injections of the blood thinner heparin that was later found to have been contaminated at pharmaceutical giant Baxter International’s manufacturing plant in China.
The FDA later admitted that it simply didn’t have the manpower to inspect all foreign food and drug manufacturing plants and thus couldn’t ensure the safety of those products. Late last year, the agency began placing food and drug inspectors to oversee the safety of foods and drugs imported into the U.S. The first three offices were opened in China.
Allowing Americans to purchase their drugs from foreign countries can provide a tremendous savings to consumers, but some lawmakers say that it is too risky a gamble. At a hearing of the Senate Finance Committee, Kansas Republican Pat Roberts asked the White House if it was in favor of first establishing some controls before moving forward with the importation plans. “Would you also agree that, if such a proposal were to move forward, we should demand that any drug imported into the U.S. meet the same high safety and efficacy standards of our FDA including bioequivalency standards?” he asked.
White House budget director Peter Orszag answered by simply saying, “Yes.”
![[ Beasley Allen Law Firm Logo ]](http://www.heparin-legal.com/wp-content/themes/system-unity/images/logo.png)
